M2‐like macrophage markers (CD163 and CD204) and CD163/CD68 and CD204/CD68 cell ratios are significantly elevated in idiopathic pulmonary fibrosis (IPF) patients, associating with shorter overall survival and time‐to‐acute exacerbation in IPF patients.59 This evidence concerns the gene CD68 and pulmonary fibrosis.